CINRYZE with rHuPH20
0624-204
Phase 2 mab completed
Quick answer
CINRYZE with rHuPH20 for Hereditary Angioedema is a Phase 2 program (mab) at HALOZYME THERAPEUTICS, INC. with 1 ClinicalTrials.gov record(s).
Program details
- Company
- HALOZYME THERAPEUTICS, INC.
- Indication
- Hereditary Angioedema
- Phase
- Phase 2
- Modality
- mab
- Status
- completed